Extracorporeal membrane oxygenation (ECMO) can be effective for refractory acute respiratory distress syndrome (ARDS) in patients with influenza, but its utility in patients with coronavirus disease 2019 (COVID-19) is uncertain. We compared outcomes of patients with refractory ARDS from COVID-19 and influenza placed on ECMO.
Outcomes of Extracorporeal Membrane Oxygenation in Patients with Severe Acute Respiratory Distress Syndrome Caused by COVID-19 Versus Influenza
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2021.05.060
Keywords:
Author(s): Emily Shih, MD
John J. Squiers, MD
J. Michael DiMaio, MD
Timothy George, MD
Jasjit Banwait, PhD
Kara Monday, MD
Britton Blough, MD
Dan Meyer, MD
Gary S. Schwartz, MD